Close
$2.83
+0.71% · day range $2.75–$2.85

NEW YORK, August 21, 2026, 08:21 EDT — Ambev S.A. saw high premarket activity in the U.S., ending Thursday’s session at $2.83 as 107.9 million ADRs were traded, more than triple its three-month average. Despite the $305 million volume—3.8 times typical levels—the stock gained just 0.71%.
Operating cash flow rose 54.5%, while normalized profit increased 23.3%.
R$20.15B revenue was 3.25% below the R$20.83B displayed estimate.
Follow-through matters more than the one-day volume spike.
| Measure | Result | Year on year |
|---|---|---|
| Net revenue | R$20.15B | +6.1% organic |
| Normalized EBITDA | R$6.38B | +8.9% organic |
| EBITDA margin | 31.6% | +80 bp |
| Normalized profit | R$3.49B | +23.3% |
| Consolidated volume | — | +1.4% organic |